[en] The involvement of bradykinin, 5-hydroxytryptamine, substance P and prostanoids in the hyperalgesia elicited by collagenase in rat paw was investigated. Collagenase (100 micrograms) induced a slight hyperalgesia in kininogen deficient rats in comparison with the behavioural response obtained in normal rats. Lisinopril (10(-5) M), and angiotensin-converting enzyme inhibitor, increased the duration of the hyperalgesia elicited in normal rats. Ondansetron (0.5 to 5 mumol/kg), a 5-HT3 antagonist, suppressed the hyperalgesia as did methysergide (1.1 to 11 mumol/kg), a mixed 5-HT1 and 5-HT2 receptor antagonist. However, the hyperalgesia was not modified by RP 67580 (1.8 to 18 mumol/kg), a NK1 receptor antagonist, and was only slightly delayed by indomethacin (2 mg/kg), a cyclo-oxygenase inhibitor. The oedema-promoting effect of 5-HT (6 nmol) was inhibited by methysergide but not by ondansetron. The swelling induced by collagenase in rat paw was reduced by methysergide but not by ondansetron. We conclude that the behavioural response induced by collagenase depends on an interactions between bradykinin and 5-HT. Prostanoids play a minor role in the beginning of the reaction whereas substance P is not significantly involved in this hyperalgesia.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Damas, Jacques ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Liégeois, Jean-François ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Bourdon, V.
Language :
English
Title :
Involvement of 5-Hydroxytryptamine and Bradykinin in the Hyperalgesia Induced in Rats by Collagenase from Clostridium Histolyticum
Armstrong D (1970) Pain. In Erdös EG (ed) Bradykinin, kallidin and kallikrein. Handbook of experimental pharmacology vol. 25. Springer Berlin Heidelberg New York, pp 434-481
Armstrong D, Jepson JB, Keele CA, Stewart JM (1957) Pain producing substance in human inflammatory exudates and plasma. J Physiol 135:350-370
Barlas Ag, Gao X, Greenbaum LM (1987) Isolation of a thiol-activated T-kininogenase from the rat submandibulur gland. FEBS Lett 218:266-270
Cohen RH, Perl ER (1990) Contributions of arachidonic derivatives and substance P to the sensitization of cutaneous nociceptors. J Neurophysiol 64:457-464
Correa CR, Kyle DJ, Chakravarty S, Calixto JB (1996) Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol 117:552-558
Damas J (1995) Thermolytic salivation, substance P and kinins in rats. Arch Physiol Biochem 103:476-483
Damas J (1996) The Brown Norway rats and the kinin system. Peptides 17:859-872
Damas J, Bourdon V, Liégeois JF, Simmons WH (1996) Influence of several peptidase inhibitors on the pro-inflammatory effects of substance P, capsaicin and collagenase. Naunyn-Schmiedeberg's Arch Pharamcol 354:662-669
De Koninck Y, Henry JL (1991) Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc Natl Acad Sci USA 88:11344-11348
Dray A, Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurol Sci 16:99-104
Ferreira SH (1972) Prostaglandins, aspirin-like drugs and analgesia. Nature 240:200-203
Ferreira SH, Moncada S, Vane JR (1973) Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 49:86-97
Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron P (1991) Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 88:10208-10212
Hong Y, Abbott FV (1994) Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63:827-836
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharance EJ, Saxena PR, Humphrey PPA (1994) VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
Kato H, Enjyoji KI, Miyata T, Hayashi I, Oh-ishi S, Iwanga S (1985) Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins. Biochim Biophys Res Commun 127:289-295
Kessler W, Kirchhoff C, Reeh PW, Handwerker HO (1992) Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res 91:467-476
Legat FJ, Griesbacher T, Lembeck F (1993) Bradykinin is the main mediator of collagenase-induced oedema in the rat paw. Br J Pharmacol 108:57P
Legat FJ, Griesbacher T, Lembeck F (1994) Mediation of bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum. Br J Pharmacol 112:453-460
Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310:175-183
Lembeck F, Juan H (1974) Interaction of prostaglandins and indomethacin with algesic agents. Naunyn-Schmiedeberg's Arch Pharmacol 285:301-313
Maling HM, Webster ME, Williams MA, Saul W, Anderson W (1974) Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: antagonists and mechanisms of action. J Pharmacol Exp Ther 191:300-310
Mizimura K, Sato J, Kumazawa T (1987) Effects of prostaglandins and other putative chemical intermediaries on the activity of canine polymodal receptors studied in vitro. Pflügers Arch 408:565-572
Perkins MN, Kelly D, Davis AJ (1995) Bradykinin B1 and B2 receptor mechanisms and cytokinine-induced hyperalgesia in the rat. Can J Physiol Pharmacol 73:832-836
Proud D, Kaplan AP (1988) Kinin formation: Mechanisms and role in inflammation disorders. Ann Rev Immunol 6:49-83
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126-131
Seguin L, Le Marouille-Girardon S, Millan MJ (1995) Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonist: a comparison to other classes of antinociceptive agent. Pain 61:325-343
Sicuteri F, Franchi G, Fanciullaci M, Del Bianco PL (1965) Serotonin bradykinin potentiation of the pain receptors in man. Life Sci 4:309-316
Souza Pinto JC, Remacle-Volon G, Sampaio CAM, Damas J (1995) Collagenase-induced oedema in the rat paw and the kinin system. Eur J Pharmacol 274:101-107
Sufka KJ, Schomberg FM, Giordano J (1992) Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 41:53-56
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235
Vargaftig BB, Lefort J, Giroux EL (1976) Haemorrhagic and inflammatory properties of collagenase from C histolyticum. Agents Actions 6:627-635